EBAY
49
-10
NEM
50
2
RHI
27
2
XOM
57
-2
GM
65
2
MS
59
-2
BLK
69
5
GME
46
4
ACN
40
4
AON
62
2
TAP
51
4
STX
73
-2
MCHP
73
4
ABBV
66
7
BBY
44
-2
SLB
42
-2
VLO
56
-6
AMZN
51
-2
XYL
58
2
HRL
33
3
EBAY
49
-10
NEM
50
2
RHI
27
2
XOM
57
-2
GM
65
2
MS
59
-2
BLK
69
5
GME
46
4
ACN
40
4
AON
62
2
TAP
51
4
STX
73
-2
MCHP
73
4
ABBV
66
7
BBY
44
-2
SLB
42
-2
VLO
56
-6
AMZN
51
-2
XYL
58
2
HRL
33
3
Financhill
Back

BridgeBio Pharma Stock Predictions

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
50

BBIO
BridgeBio Pharma

Last Price:
$47.10
Seasonality Move:
8.94%

7 Day Trial

ALL ACCESS PASS

$ 7

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 43.6% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $47.10. The Score for BBIO is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 43.6% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
50
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BBIO is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
48.68
52-Week Low:
21.72

Prediction Charts

Market Cap:
8.9B
Price in USD:
47.10
Volume:
2.6M
Beta:
1.06

Technical Analysis

SMA50:
39.18
SMA100:
36.78
SMA200:
32.42
52-Wk Change:
61.03%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 47.10 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-26 44.95 45.12 45.13 43.78
Jun-27 45.18 44.86 45.48 44.20
Jun-30 45.13 43.18 45.23 42.94
Jul-1 43.00 42.78 43.04 41.80
Jul-2 42.42 42.83 43.16 42.12
Jul-3 42.63 43.99 44.07 42.29
Jul-7 43.77 43.50 43.77 42.95
Jul-8 43.68 43.19 44.03 43.15
Jul-9 44.26 45.98 46.43 43.91
Jul-10 46.09 46.27 46.80 45.93
Jul-11 45.98 46.47 46.76 45.73
Jul-14 47.34 47.69 48.68 46.80
Jul-15 48.19 46.97 48.42 46.63
Jul-16 47.29 47.10 47.66 46.70

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.22 per share, an increase next quarter of $0.19 per share, an increase this year of $0.17 per share, and an increase next year of $0.47 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.